New York, Jan 20, 2026, 13:20 EST — Regular session
- Honeywell shares down about 1.7% in afternoon trading as U.S. stocks slide.
- Volatility gauges jump as investors react to fresh tariff threats tied to Greenland dispute.
- Bloomberg reports Honeywell-backed Quantinuum is working with Morgan Stanley and JPMorgan on an IPO.
Honeywell International Inc. shares were down 1.7% at $215.57 in afternoon trading on Tuesday, after earlier touching $219.50. The stock was off $3.82 from its previous close, with volume around 2.5 million shares.
The drop came as U.S. stocks slid toward three-week lows after President Donald Trump threatened additional tariffs on eight European countries unless Washington is allowed to buy Greenland. The proposed duties would start at 10% on Feb. 1 and climb to 25% on June 1, Trump wrote on Truth Social, while industrial bellwether 3M fell sharply after forecasting annual adjusted profit a touch below expectations. “We think we’ll settle down and realize this is just a negotiation tool,” Jeff Buchbinder, chief equity strategist at LPL Financial, said. Reuters
Nerves showed up in the Cboe Volatility Index — the VIX, an options-based gauge of expected swings in U.S. stocks — which hit an eight-week high above 20. “It’s pretty standard reaction to geopolitical turmoil, take equity risk off table, buy gold, buy cash,” said Alex Morris, CEO and CIO of F/m Investments. Michael Brown, a market analyst at Pepperstone, said the moves “feel” worse than they may be after a long stretch of calm trading. Reuters
Honeywell also has a company-specific thread in the background. Quantinuum, the quantum computing company backed by Honeywell, is working with Morgan Stanley and JPMorgan Chase on a potential IPO — an initial public offering, when a company sells shares to the public for the first time — Bloomberg News reported, citing people familiar with the matter. The report said Quantinuum is seeking to complete a first-time share sale as soon as the first half of this year.
Any float is still months away and market windows can shut fast when headlines turn. For now, HON is trading like a big-cap industrial: it follows the tape when investors rush into cash.
The next hard catalyst is earnings. Honeywell said it will issue fourth-quarter results and a 2026 outlook before the Nasdaq opens on Thursday, Jan. 29, followed by an 8:30 a.m. EST conference call.
That update lands at a touchy moment for cyclicals. Guidance — and how management frames demand — could matter more than the quarter.
Quantinuum’s IPO talk is a separate lever, but it is not today’s lever. It gives investors another thing to price if markets settle, and one more line of questioning for executives.
But the path is messy. If tariff threats harden into policy or negotiations drag on, industrial names can take another hit on valuation and on confidence, and any delay to a Quantinuum deal would leave little to offset the macro mood.
Traders are watching for signs the tariff rhetoric cools and whether volatility keeps climbing. Honeywell’s Jan. 29 results and outlook are the next scheduled marker for HON.
